Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Public ClinicalTrials.gov record NCT02836873. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This was a phase 3, multi-center, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of oral administration of bexagliflozin at 20 mg versus placebo in subjects with T2DM, moderate renal impairment and inadequate glycemic control.
Study identification
- NCT ID
- NCT02836873
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 312 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 20 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 23, 2016 (Actual)
- Primary completion
- Jan 11, 2018 (Actual)
- Completion
- Jan 11, 2018 (Actual)
- Last update posted
- Jun 30, 2021
2016 – 2018
United States locations
- U.S. sites
- 23
- U.S. states
- 11
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Fresno | California | 93720 | — |
| Research Site | La Palma | California | 90623 | — |
| Research Site | Lincoln | California | 95648 | — |
| Research Site | Riverside | California | 92505 | — |
| Research Site | Sacramento | California | 95825 | — |
| Research Site | San Dimas | California | 91773 | — |
| Research Site | Monument | Colorado | 80132 | — |
| Research Site | Norwalk | Connecticut | 06851 | — |
| Research Site | Hollywood | Florida | 33024 | — |
| Research Site | Tampa | Florida | 33607 | — |
| Research Site | West Palm Beach | Florida | 33401 | — |
| Research Site | Paducah | Kentucky | 42003 | — |
| Research Site | Auburn | Maine | 04210 | — |
| Research Site | Rockport | Maine | 04856 | — |
| Research Site | Nashua | New Hampshire | 03063 | — |
| Research Site | The Bronx | New York | 10461 | — |
| Research Site | Stow | Ohio | 44224 | — |
| Research Site | Oklahoma City | Oklahoma | 73112 | — |
| Research Site | Austin | Texas | 78731 | — |
| Research Site | Austin | Texas | 78758 | — |
| Research Site | North Richland Hills | Texas | 76180 | — |
| Research Site | Round Rock | Texas | 78681 | — |
| Research Site | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02836873, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 30, 2021 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02836873 live on ClinicalTrials.gov.